Cholinergic Pharmacology II Flashcards
cholinoreceptor blocking drugs divided into
muscarinic antagonists and nicotinic antagnosts
antimuscarinic drugs come in two types
tertiary amines (effects in eye or CNS) and quaternary amines (peripheral effects, cannot penetrate lipid)
prototypical drug is atropine
atropine
causes reversible (competitive blockage) and is not selective between M1, M2, and M3 subtypes
Nicotinic antagonists are
ganglion blockers, nmj blockers (paralytics)
Cholinoreceptor blocking drugs- organ system effects: CNS
profound effects at higher, toxic doses
agitation, hallucinations, coma
often used with dopamine precursor in parkinson’s
cholinoreceptor blocking drugs- organ system effects: eye
activation constricts pupil
-blockade results in dilation and blurry vision (blockade by topical atropine) by causing paralysis of ciliary muscle (used in ophthalmic exam- cyclopegia)
-contraindicated in acute glaucoma, especially in pts with narrow anterior chamber angle
cholinoreceptor blocking drugs- organ system effects: CV
SA node is under PNS tone- sensitive to muscarinic blockade
- atropine produces tachycardia
- antimuscarinics can cause cutaneous vasodilation
cholinoreceptor blocking drugs- organ system effects: respiration, GI, GU, sweat
respiratory- bronchodilation and reduction of secretion (more important), used in asthma or allergies but not first line
gi tract- predominant tone is parasympathetic, reduces motility and secretion; useful as preop adjuvant before abd surgery
gu tract- urinary retention, esp with BPH
sweat glands- suppresses thermoregulatory sweating (under sympathetic control but cholinergic), body temp elevation
therapeutic applications for cholinoreceptor blocking drugs
parkinson’s, motion sickness, preop meds, relieves bronchoconstriction (ipratropium plus beta2 agonists in asthma and copd), relief of vagal syncope, traveler’s diarrhea, urinary urgency and incontinence, reversal of cholinergic poisoning (w/ tertiary drug), hyperhidrosis
atropine poisoning
dry mouth, mydriasis, tachycardia, flushed skin, delirium- “dry as a bone, blind as a bat, red as a beet, mad as a hatter”
-can be treated with physostigmine (cholinesterase inhibitor) or symptom management
contraindications of cholinoreceptor blocking drugs
glaucoma (closed angle)
and prostatic hyperplasia because you can promote urinary retention
ganglion blocking drugs
- block actions of ADh and other agonists at nicotinic receptors
- receptors on both PNS and SNS autonomic ganglia (post ganglionic neurons that leave from paravertebral chains of SNS or peripheral ganglia for PNS)
- non selective produces limited side effect profiles
- all synthetic amines
-wherever the blockade is, blocking sympathetic reflex will result in orthostatic hypotension
first ganglion blocking drug developed was
tetraethylammonium (TEA)- short doa
- developed for management of htn and effective
- block sympathetic outflow to peripheral vasculature- specific because tone of peripheral vasculature is sympathetic
- however, vessels won’t be able to adapt to change (no vasoconstriction to maintain perfusion to brain after standing up)
ganglionic blockers organ system effects
-depend on predominant ANS tone at specific end organ
mecamylamine
a ganglion blocking drug which can enter the CNS- can cause sedation, tremor, choreiform movements, mental aberrations